Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcoma derived from cultured mesenchymal stem cells.

Jakub Tolar1, Alma J Nauta, Mark J Osborn

  • 1Department of Pediatrics, Division of Hematology-Oncology, Blood and Marrow Transplant and Cancer Center, University of Minnesota Medical School, Minneapolis, Minnesota, USA. tolar003@umn.edu

Stem Cells (Dayton, Ohio)
|October 14, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Mapping and Phenotypic Characterization of the <i>Drosophila</i> <i>AIF <sup>e04281</sup></i> Allele Reveals Mutant Clone Loss in Mosaic Eyes.

microPublication biology·2025
Same author

Erratum: Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

The <i>M.3.2</i> mutation in <i>Drosophila melanogaster</i> mapped as a novel allele of ​​ <i>tout-velu</i>.

microPublication biology·2025
Same author

Genome sequences of actinobacteriophages JorRay, Blocker23, Nibbles, and OlgasClover.

Microbiology resource announcements·2024
Same author

Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.

Blood advances·2024
Same journal

Brent A. Reynolds, pioneer of adult neural stem cell biology.

Stem cells (Dayton, Ohio)·2026
Same journal

CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.

Stem cells (Dayton, Ohio)·2026
Same journal

Transforming Growth Factor beta-2 (TGFβ2) Drives Trabecular Meshwork Progenitor Cell Differentiation Through SMAD2/3 Signalling.

Stem cells (Dayton, Ohio)·2026
Same journal

Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.

Stem cells (Dayton, Ohio)·2026
Same journal

Regeneration of the mammalian brain: a relic of evolution?

Stem cells (Dayton, Ohio)·2026
Same journal

Mitochondrial transfer technologies with molecular insights into clinical applications.

Stem cells (Dayton, Ohio)·2026
See all related articles
This summary is machine-generated.

Mesenchymal stem cells (MSCs) labeled for tracking unexpectedly developed sarcoma in mice. This study highlights the potential for sarcoma evolution from MSC cultures, even without specific genetic abnormalities.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Regenerative Medicine

Background:

  • Mesenchymal stem cells (MSCs) are widely studied for therapeutic potential.
  • Tracking MSC biodistribution is crucial for understanding their in vivo behavior.
  • Nonviral gene delivery methods are used to label cells for tracking.

Purpose of the Study:

  • To investigate the biodistribution of labeled MSCs in vivo.
  • To identify potential risks associated with MSC labeling and transplantation.
  • To characterize any unexpected cellular transformations.

Main Methods:

  • Adult murine MSCs were labeled with luciferase and DsRed2 using Sleeping Beauty transposons.
  • Labeled MSCs were coinfused with bone marrow into irradiated allogeneic recipients.

Related Experiment Videos

  • In vivo whole-body imaging was used to monitor luciferase signals.
  • Tumor cells were isolated and analyzed for cytogenetic abnormalities.

    • Main Results:

    • Increased luciferase signals were observed between weeks 3 and 12 post-infusion.
    • Unexpectedly, some mice developed sarcomas in lungs and extremities.
    • Cytogenetic abnormalities were identified in tumor cells, and MSC cultures showed aberrations after passages.
    • Clonal evolution was observed in vivo, suggesting transformation occurred before infusion.
    • A novel bioluminescent and fluorescent sarcoma cell line (S1) was established.

    Conclusions:

    • Sarcoma can spontaneously evolve from cultured MSCs.
    • The transformation appears to be a common event in vitro, not strain-specific.
    • The S1 cell line provides a tool for studying sarcoma biology and therapeutic responses.